Zopiclone (Zimovane): insomnia use, driving, dependence and withdrawal
Zopiclone safety and short-term insomnia use: next-day driving, overdose, complex sleep behaviour, interactions, dependence, withdrawal and funding limits.
Evidence-graded research on sleep and insomnia — melatonin, magnesium and other sleep supplements assessed by the real strength of the primary evidence.
Zopiclone safety and short-term insomnia use: next-day driving, overdose, complex sleep behaviour, interactions, dependence, withdrawal and funding limits.
Zolpidem helps people fall asleep a little faster for a few weeks. Independent evidence on its benefits, FDA boxed warning, driving risk, dependence and falls.
Trazodone is licensed for depression but mostly prescribed off-label for sleep. Independent evidence on benefits, falls, priapism, withdrawal and funding.
Temazepam helps short-term insomnia modestly, but carries FDA boxed warnings on opioids, dependence and withdrawal. What independent evidence says, and who funded it.
Suvorexant (Belsomra) modestly helps people stay asleep. Independent evidence on the FDA dose fight, next-day driving risk, side effects and Merck-funded trials.
Mirtazapine works for depression, but sedation and weight gain are common. Off-label use for insomnia rests on thin evidence. Who funded the trials?
Lemborexant (Dayvigo) ranks well in the Lancet 2022 insomnia-drug comparison, but long-term evidence is weak and the pivotal trials were Eisai-funded.
Eszopiclone gives modest short-term sleep gains in mostly company-funded trials. Independent evidence on benefits, FDA boxed warning, next-day impairment and falls.
Low-dose doxepin (3–6 mg) adds about half an hour of sleep for night waking, with placebo-like side effects. Independent evidence, risks and who funded the trials.
Daridorexant (Quviviq) gives small gains over placebo for chronic insomnia with no withdrawal in trials. NICE backs it after CBTi; key trials were Idorsia-funded.
Get the topics, key findings and links from our new articles in one email. At most one digest a day, only when there is something new.